BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2164496)

  • 21. Screening for late-onset congenital adrenal hyperplasia in hirsutism or amenorrhea.
    Baskin HJ
    Arch Intern Med; 1987 May; 147(5):847-8. PubMed ID: 3579438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-onset adrenal hyperplasia in hirsutism.
    Kuttenn F; Couillin P; Girard F; Billaud L; Vincens M; Boucekkine C; Thalabard JC; Maudelonde T; Spritzer P; Mowszowicz I
    N Engl J Med; 1985 Jul; 313(4):224-31. PubMed ID: 2989686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study.
    Moran C; Azziz R; Carmina E; Dewailly D; Fruzzetti F; Ibañez L; Knochenhauer ES; Marcondes JA; Mendonca BB; Pignatelli D; Pugeat M; Rohmer V; Speiser PW; Witchel SF
    Am J Obstet Gynecol; 2000 Dec; 183(6):1468-74. PubMed ID: 11120512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Acquired" adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorders as congenital adrenal hyperplasia.
    New MI; Lorenzen F; Pang S; Gunczler P; Dupont B; Levine LS
    J Clin Endocrinol Metab; 1979 Feb; 48(2):356-9. PubMed ID: 218988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA and hormonal studies in 5 patients with late-onset 21-hydroxylase deficiency syndrome (21OHDS).
    Scaroni C; Orlandini E; Venturi Pasini C; Gangemi M; Mantero F
    J Endocrinol Invest; 1986 Feb; 9(1):65-70. PubMed ID: 3009598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
    Sahmay S; Tuten A; Gurleyen H; Oncul M; Benian A; Tamer Erel C
    Minerva Endocrinol; 2014 Sep; 39(3):215-22. PubMed ID: 25068307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hirsutism in Chilean women: importance of 21-hydroxylase congenital deficiency of late onset].
    Gallardo E; Porcile A
    Rev Med Chil; 1991 Feb; 119(2):147-51. PubMed ID: 1824156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined 21- and 11 beta-hydroxylase deficiency in familial congenital adrenal hyperplasia.
    Hurwitz A; Brautbar C; Milwidsky A; Vecsei P; Milewicz A; Navot D; Rösler A
    J Clin Endocrinol Metab; 1985 Apr; 60(4):631-8. PubMed ID: 2982904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations.
    Chrousos GP; Loriaux DL; Mann D; Cutler GB
    Horm Res; 1982; 16(4):193-200. PubMed ID: 6290362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
    Speiser PW; New MI
    J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late onset adrenal hyperplasia due to 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency in north Indian hirsute women.
    Sundararaman PG; Ammini AC; Khurana ML; Karmarkar MG; Ahuja MM
    Indian J Med Res; 1997 Jan; 105():27-31. PubMed ID: 9029832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
    Lobo RA; Goebelsmann U
    Am J Obstet Gynecol; 1980 Nov; 138(6):720-6. PubMed ID: 6254362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of late onset congenital adrenal hyperplasia].
    Rouach M; Blumenfeld Z
    Harefuah; 1993 Mar; 124(5):249-53, 320. PubMed ID: 8495912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
    Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
    J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche.
    Ibáñez L; Bonnin MR; Zampolli M; Prat N; Alia PJ; Navarro MA
    Horm Res; 1995; 44(2):51-6. PubMed ID: 7590632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late onset adrenal hyperplasia (21-hydroxylase deficiency): 17-OH progesterone response to ACTH stimulation and HLA typing. A family study.
    Kauschansky A; Kaufman H; Zamir R; Elian E
    Horm Res; 1981; 14(2):73-8. PubMed ID: 6268517
    [No Abstract]   [Full Text] [Related]  

  • 37. New reliable biochemical marker for screening 21 alpha-hydroxylase deficiency without index person among hirsute women in agreement with HLA-haplotyping.
    Chryssikopoulos A; Phocas I; Sarandakou A; Trakakis E; Rizos D
    J Endocrinol Invest; 1995 Nov; 18(10):754-61. PubMed ID: 8787951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY; Wallace MA; Hofman L; Thuline HC; Dorche C; Lyon IC; Dobbins RH; Kling S; Fujieda K; Suwa S
    Pediatrics; 1988 Jun; 81(6):866-74. PubMed ID: 3259306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital adrenal hyperplasia due to partial 21-hydroxylase deficiency. A study of five cases.
    Bouchard P; Kuttenn F; Mowszowicz I; Schaison G; Raux-Eurin MC; Mauvais-Jarvis P
    Acta Endocrinol (Copenh); 1981 Jan; 96(1):107-11. PubMed ID: 6257014
    [No Abstract]   [Full Text] [Related]  

  • 40. 'Cryptic' form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in the Yugoslav population.
    Dumić M; Brkljacić L; Mardesić D; Plavsić V; Lukenda M; Kastelan A
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):386-92. PubMed ID: 2992207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.